Login / Signup

Silent existence of eosinopenia in sepsis: a systematic review and meta-analysis.

Yao LinJiabing RongZhaocai Zhang
Published in: BMC infectious diseases (2021)
Our findings suggested that Eosinopenia has a high incidence in sepsis but has no superiority in comparison with conventional biomarkers for diagnosis of sepsis. However, eosinopenia can still be used in clinical diagnosis for sepsis as a simple, convenient, fast and inexpensive biomarker. Therefore, further large clinical trials are still needed to re-evaluate eosinopenia as a biomarker of sepsis.
Keyphrases
  • septic shock
  • acute kidney injury
  • intensive care unit
  • clinical trial
  • randomized controlled trial
  • open label
  • phase ii
  • study protocol